Log in to save to my catalogue

Antitumor activity of bovine lactoferrin and its derived peptides against HepG2 liver cancer cells a...

Antitumor activity of bovine lactoferrin and its derived peptides against HepG2 liver cancer cells a...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2812885490

Antitumor activity of bovine lactoferrin and its derived peptides against HepG2 liver cancer cells and Jurkat leukemia cells

About this item

Full title

Antitumor activity of bovine lactoferrin and its derived peptides against HepG2 liver cancer cells and Jurkat leukemia cells

Publisher

Dordrecht: Springer Netherlands

Journal title

Biometals, 2023-06, Vol.36 (3), p.639-655

Language

English

Formats

Publication information

Publisher

Dordrecht: Springer Netherlands

More information

Scope and Contents

Contents

Liver cancer and leukemia are the fourth and first causes, respectively, of cancer death in children and adults worldwide. Moreover, cancer treatments, although beneficial, remain expensive, invasive, toxic, and affect the patient’s quality of life. Therefore, new anticancer agents are needed to improve existing agents. Because bovine lactoferrin (...

Alternative Titles

Full title

Antitumor activity of bovine lactoferrin and its derived peptides against HepG2 liver cancer cells and Jurkat leukemia cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_2812885490

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2812885490

Other Identifiers

ISSN

0966-0844

E-ISSN

1572-8773

DOI

10.1007/s10534-022-00484-4

How to access this item